0.79
+0.0065(+0.83%)
Currency In USD
| Previous Close | 0.79 |
| Open | 0.78 |
| Day High | 0.81 |
| Day Low | 0.77 |
| 52-Week High | 1.39 |
| 52-Week Low | 0.4 |
| Volume | 163,138 |
| Average Volume | 399,120 |
| Market Cap | 39.55M |
| PE | -4.95 |
| EPS | -0.16 |
| Moving Average 50 Days | 0.86 |
| Moving Average 200 Days | 0.83 |
| Change | 0.01 |
If you invested $1000 in NeuroOne Medical Technologies Corporation (NMTC) since IPO date, it would be worth $65.67 as of October 31, 2025 at a share price of $0.792. Whereas If you bought $1000 worth of NeuroOne Medical Technologies Corporation (NMTC) shares 4 years ago, it would be worth $235.71 as of October 31, 2025 at a share price of $0.792.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
NeuroOne® to Participate in Sidoti Small-Cap Conference on September 17th and 18th, 2025
GlobeNewswire Inc.
Sep 08, 2025 8:05 PM GMT
EDEN PRAIRIE, Minn., Sept. 08, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffer
NeuroOne® Receives FDA 510(k) Clearance for OneRF® Trigeminal Nerve Ablation System to Treat Facial Pain
GlobeNewswire Inc.
Aug 18, 2025 12:30 PM GMT
FDA Clearance Further Validates Technology Platform and Offers Alternatives to Pharmaceutical and Invasive Surgical Treatments EDEN PRAIRIE, Minn., Aug. 18, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOn
NeuroOne® to Report Third Quarter Fiscal Year 2025 Financial Results on Thursday, August 14 at 8:30 a.m. Eastern Time - Update
GlobeNewswire Inc.
Jul 31, 2025 4:12 PM GMT
EDEN PRAIRIE, Minn., July 31, 2025 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients sufferi